Save time and get answers to complex questions with AI chat
Tenofovir generic patent?Are there income restrictions for lipitor's patient program?Complera manufacturer?Is guselkumab off patent in u s?What excipients are combined with ruxolitinib in apotex's medication?
See the DrugPatentWatch profile for Digoxin
Digoxin is a cardiac glycoside. It works mainly on the heart to slow the heart rate and increase the force of contraction.
Digoxin is commonly classified as: - A cardiac glycoside (pharmacologic class) - A positive inotrope used for heart conditions (functional use)
Digoxin is grouped with other cardiac glycosides because it inhibits the Na+/K+ ATPase pump in heart cells, which indirectly increases intracellular calcium. That increased calcium is what boosts contraction strength and helps control heart rate.
Digoxin’s medical uses (commonly atrial fibrillation/flutter for rate control and certain types of heart failure to improve symptoms) don’t change its core drug class: it remains a cardiac glycoside based on its mechanism.
Digoxin is often used for rhythm- and rate-related indications (especially atrial fibrillation/flutter), so it’s sometimes grouped with antiarrhythmic medicines in practice. But mechanistically and pharmacologically, it is still classified as a cardiac glycoside.
Other Questions About Digoxin :